import { PeptidePageTemplate } from "@/components/PeptidePageTemplate";
import { ProductJsonLd } from "@/components/ProductJsonLd";
import { useDocumentMeta } from "@/hooks/useDocumentMeta";

const AOD9604 = () => {
  useDocumentMeta({
    title: "AOD-9604 | Peptide Foundry - Premium Research Peptides",
    description: "Buy high-purity AOD-9604 research peptide from Peptide Foundry. A peptide studied for fat metabolism, lipolysis, and body composition. Verified quality, fast shipping.",
    canonicalPath: "/aod-9604",
    ogType: "product",
  });
  return (
  <>
  <ProductJsonLd
    name="AOD-9604 Research Peptide"
    description="AOD-9604 is a modified fragment of the C-terminus of human growth hormone (HGH), specifically amino acids 176-191. This synthetic peptide retains lipolytic signaling activity in adipocyte models while lacking the glycemic effects associated with full-length HGH."
    slug="aod-9604"
    price={82}
    casNumber="221231-10-3"
  />
  <PeptidePageTemplate
    slug="aod-9604"
    price={82}
    peptideName="AOD-9604"
    productImage="/products/aod-9604.webp"
    coaSlot={<img src="/coa/aod-9604.png" alt="AOD-9604 COA" className="w-full h-auto" />}
    subtitle="A peptide studied in laboratory settings for fat metabolism, lipolysis, and body composition"
    description="AOD-9604 is a modified fragment of the C-terminus of human growth hormone (HGH), specifically amino acids 176-191. This synthetic peptide retains lipolytic signaling activity in adipocyte models while lacking the glycemic effects associated with full-length HGH."
    casNumber="221231-10-3"
    molecularFormula="C₇₈H₁₂₃N₂₃O₂₃S₂"
    molarMass="1815.08 g/mol"
    benefits={[
      { iconName: "Flame", iconBgClass: "bg-orange-100 dark:bg-orange-900/30", title: "Enhanced Fat Loss", description: "Stimulates lipolysis (fat breakdown) specifically in adipose tissue without affecting lean muscle mass or blood glucose levels.", link: "https://doi.org/10.1210/jcem.86.7.7645" },
      { iconName: "TrendingDown", iconBgClass: "bg-green-100 dark:bg-green-900/30", title: "Metabolic Optimization", description: "Increases metabolic rate and energy expenditure, promoting efficient fat oxidation and improved body composition.", link: "https://doi.org/10.1016/j.metabol.2008.11.017" },
      { iconName: "Droplets", iconBgClass: "bg-blue-100 dark:bg-blue-900/30", title: "Lipogenesis Inhibition", description: "Prevents new fat formation by inhibiting lipogenic pathways, reducing triglyceride accumulation in adipocytes.", link: "https://doi.org/10.1111/j.1365-2826.2009.01848.x" },
      { iconName: "Activity", iconBgClass: "bg-purple-100 dark:bg-purple-900/30", title: "No Insulin Disruption", description: "Promotes fat loss without affecting insulin sensitivity or glucose metabolism, unlike full-length growth hormone.", link: "https://doi.org/10.1210/endo.142.4.8082" },
      { iconName: "Zap", iconBgClass: "bg-yellow-100 dark:bg-yellow-900/30", title: "Energy Enhancement", description: "Increases cellular energy production through enhanced mitochondrial fatty acid oxidation and ATP synthesis.", link: "https://doi.org/10.1038/sj.ijo.0803408" },
      { iconName: "Heart", iconBgClass: "bg-red-100 dark:bg-red-900/30", title: "Cardiovascular Support", description: "Reduces visceral adiposity and improves lipid profiles, supporting cardiovascular health and metabolic function.", link: "https://doi.org/10.1007/s11695-011-0560-5" }
    ]}
    references={[
      "Heffernan MA, et al. A synthetic fragment of human growth hormone (AOD9604) inhibits lipogenesis and stimulates lipolysis. Obesity Research. 2001.",
      "Heffernan M, et al. The effects of chronic AOD9604 treatment in obese Zucker rats. Molecular and Cellular Endocrinology. 2001.",
      "Ng FM, et al. AOD9604 potentiates lipolysis by enhancing the beta-adrenergic signaling pathway. Endocrinology. 2000.",
      "Stier H, et al. Growth hormone and AOD9604 effects on lipolysis in human adipose tissue. Journal of Clinical Endocrinology & Metabolism. 2003."
    ]}
    aboutParagraphs={[
      "AOD-9604 got its start in the late 1990s at Monash University in Australia. Researchers there were investigating whether a fragment of the growth hormone molecule could retain lipolytic signaling activity in adipocyte models without the glycemic and proliferative effects of the full-length protein.",
      "The team identified that amino acids 176 to 191 of the growth hormone sequence exhibited lipolytic signaling in adipose tissue models without activating insulin or IGF-1-related growth pathways. They designated this fragment AOD-9604.",
      "Since then, AOD-9604 has been through multiple research studies and even some clinical trials. It caught the attention of labs worldwide looking for new ways to study fat metabolism. Today, it remains one of the most well-documented peptide fragments used in metabolic research. This product is intended for research use only."
    ]}
    howItWorksIntro="Preclinical studies have examined AOD-9604's mechanism of action involving the same lipolytic signaling pathways as growth hormone, but without observed effects on glucose metabolism, insulin sensitivity, or tissue growth in laboratory models."
    howItWorksAccordions={[
      { value: "receptor", iconName: "Target", iconBgClass: "bg-blue-100 dark:bg-blue-900/30", title: "Beta-3 Adrenergic Receptor Activation", content: "AOD-9604 selectively binds to and activates beta-3 adrenergic receptors located predominantly in adipose tissue. This activation triggers a cascade of intracellular signaling events that promote lipolysis through increased cAMP production and activation of hormone-sensitive lipase." },
      { value: "lipolysis", iconName: "Flame", iconBgClass: "bg-purple-100 dark:bg-purple-900/30", title: "Enhanced Lipolytic Activity", content: "The peptide significantly increases the rate of lipolysis by upregulating hormone-sensitive lipase and adipose triglyceride lipase activity. The released fatty acids are transported to mitochondria for beta-oxidation, generating ATP and promoting overall fat loss." },
      { value: "lipogenesis", iconName: "TrendingDown", iconBgClass: "bg-green-100 dark:bg-green-900/30", title: "Lipogenesis Inhibition", content: "AOD-9604 inhibits de novo lipogenesis by downregulating key lipogenic enzymes including fatty acid synthase and acetyl-CoA carboxylase. This dual action creates a powerful synergistic effect for body composition improvement." }
    ]}
    technicalPathways={[
      "Beta-3 adrenergic receptor binding → Gs protein activation → adenylyl cyclase stimulation → increased cAMP levels",
      "Elevated cAMP → protein kinase A (PKA) activation → phosphorylation of hormone-sensitive lipase (HSL)",
      "Activated HSL → triglyceride hydrolysis → free fatty acid and glycerol release",
      "Free fatty acids → mitochondrial transport via CPT1 → beta-oxidation → acetyl-CoA production"
    ]}
  />
  </>
  );
};

export default AOD9604;
